High-performance liquid-chromatographic assay for nitrofurantoin in plasma and urine. 1977

M B Aufrère, and B Hoener, and M E Vore

The high-performance liquid-chromatographic method described here for the quantitative analysis for nitrofurantoin in urine and plasma involves direct analysis of urine samples and analysis of plasma samples after protein precipitation by methanol. The assay, which requires only 0.2 ml of biological fluid and shows a linear relationship in the range 0.02 to 200 mg/liter, can be performed in 9 min and is reproducible (CV less than 2%). Results for nitrofurantoin so obtained correlate well with those obtained by the Hyamine 10-X spectrophotometric method (CV = 2%), but the present method is more sensitive. With no modification, the present procedure can also be used for nitrofurazone. The sensitivity, accuracy, and convenience of the method make it suitable for clinical monitoring and pharmacokinetic/bioavailability studies with 5-nitrofuran derivatives.

UI MeSH Term Description Entries
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M B Aufrère, and B Hoener, and M E Vore
May 1980, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
May 1982, Journal of pharmaceutical sciences,
M B Aufrère, and B Hoener, and M E Vore
July 1991, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
July 1984, Journal of pharmaceutical sciences,
M B Aufrère, and B Hoener, and M E Vore
February 1990, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
July 1992, Journal of pharmaceutical sciences,
M B Aufrère, and B Hoener, and M E Vore
May 1984, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
January 1989, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
March 1993, Journal of chromatography,
M B Aufrère, and B Hoener, and M E Vore
June 1995, Journal of chromatography. B, Biomedical applications,
Copied contents to your clipboard!